Report

src

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size, Share & Recession Impact Analysis, By Surgery (Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma), By Target (Trabecular Meshwork, Suprachoroidal Space and Others), By Product (MIGS Stents, MIGS Shunts and OTHER (Trabectome/micro-implants/micro catheters)), By End User (Eye Hospitals, Ophthalmology Clinics and Outpatient Surgical Centers), and Regional Forecasts, 2023-2030

Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.
The global micro invasive glaucoma surgery (MIGS) devices market size was valued at USD 315.2 million in 2022. The market is projected to grow from USD 315.2 million in 2022 to USD 2458.03 million by 2030, exhibiting a CAGR of 34.10% during the forecast period.
 
One of the main growing factors for the market for MIGS devices is the rising incidence of glaucoma. The chronic and progressive eye condition glaucoma causes damage to the optic nerve and vision loss. Glaucoma is thought to afflict 67 million people globally, and the World Health Organization (WHO) predicts that figure will rise to 82 million by the year 2020. Another important aspect influencing MIGS device growth is the technological advancements in those products. Furthermore, during the past several years, due to numerous marketing campaigns carried out by device manufacturers/distributors worldwide, there has been an increase in knowledge regarding the advantages of undergoing MIGS surgery among both patients and healthcare professionals. This is driving the growth of the market over the forecast period.
 
RECESSION IMPACT

The recession will have a significant effect on the market for micro invasive glaucoma surgery (MIGS) devices. In a downturn, people and healthcare systems might have less money available to spend on innovative medical technologies, such MIGS devices. Due to the possibility of patients choosing less expensive or conventional glaucoma operations, the market for MIGS devices may decline as a result. A recession may also result in less money being allocated to the provision of healthcare by governments or insurance companies. This may reduce the amount of money available for MIGS procedures and equipment.
 
DRIVING FACTORS

Rising Older Population to Drive Market Growth

Vision loss is a serious health concern for elderly people. The American Academy of Family Physicians estimates that by the age of 65, one in three people have an eye condition that impairs their vision. The number of old people is rising quickly. As a result, elderly folks have a greater need for cutting-edge glaucoma treatment methods. Consequently, the market is being driven by an increase in the population of elderly people. There has been an increase in glaucoma prevalence. As a result, there is a demand for MIGS devices, and it is anticipated that this would act as a driving factor for the market.
 
RESTRAINING FACTORS

High Cost of Micro Invasive Glaucoma Surgery (MIGS) Devices to Limit Market Growth

Microinvasive glaucoma surgery (MIGS) equipment's high price can have a substantial negative impact on the market. When compared to common glaucoma surgeries like trabeculectomy or tube shunt treatments, MIGS devices are frequently more expensive. The price of MIGS devices can range from several thousand to tens of thousands of dollars per device, depending on the exact device. Moreover, MIGS procedures frequently necessitate the use of many devices in combination, which raises the entire cost. Since MIGS devices are expensive, many patients might not be able to afford them, especially those who reside in underdeveloped or medically underdeveloped nations. The price of MIGS devices may prevent healthcare practitioners or insurance companies from utilising them, even in nations with developed healthcare systems.
 
SEGMENTATION

By Surgery

Micro Invasive Glaucoma Surgery (MIGS) Devices Market By Surgery
Based on surgery, the micro invasive glaucoma surgery (MIGS) devices market is segmented into glaucoma in conjunction with cataract and stand alone glaucoma. The stand alone glaucoma category dominated the market in 2022. The market for micro invasive glaucoma surgery (MIGS) devices is expected to grow as a result of important factors including the ageing population's increased susceptibility to glaucoma conditions like mild to moderate glaucoma, primary angle-closure glaucoma, and secondary angle-closure glaucoma.
 
By Target

Based on target, the micro invasive glaucoma surgery (MIGS) devices market is segmented into trabecular meshwork, suprachoroidal space and others. The trabecular meshwork category dominated the market in 2022. The switch from medication-based glaucoma treatment to minimally invasive glaucoma surgery (MIGS) devices has been prompted by the inefficient drug delivery seen in glaucoma medications, which has boosted market growth.
 
By Product

Based on product, the micro invasive glaucoma surgery (MIGS) devices market is segmented into MIGS stents, MIGS shunts and others (trabectome/micro-impants/micro-catheters). The MIGS stents category dominated the market in 2022. Small, flexible, and thin medical devices called MIGS stents are used to treat persistent open-angle glaucoma (OAG). To avoid occlusion of the anterior chamber's aqueous fluid outflow, these stents can be placed into the eye. Although their exact method of action is unknown, it is assumed that they stimulate ocular nerve fibres, which lowers intraocular pressure.
 
By End User

Based on end user, the micro invasive glaucoma surgery (MIGS) devices market is segmented into eye hospitals, ophthalmology clinics and outpatient surgical centers. The eye hospitals category dominated the market in 2022. Surgery is a surgical option for treating the persistent condition of glaucoma. It harms the optic nerve, which causes blindness and vision loss. Those who are unable to visit a doctor or health centre can receive medical care from a hospital. Hospitals can offer more thorough care since they typically have more modern facilities and equipment than clinics.
 
REGIONAL INSIGHTS

Micro Invasive Glaucoma Surgery (MIGS) Devices Market By Region 
North America is projected to hold the largest share of the micro invasive glaucoma surgery (MIGS) devices market over the forecast period. Increased cases of glaucoma and other eye problems in the area can be blamed for the region's expansion. Due to partnerships and acquisitions of significant market participants, the U.S. controls the North American region. The market players that are concentrating on strengthening their regional product offerings and their presence in emerging markets through various growth strategies, such as expansions, partnerships, and collaborations among others, are expected to fuel demand in this area. On the other hand, the Asia Pacific micro invasive glaucoma surgery (MIGS) devices market is anticipated to grow significantly. Developing healthcare infrastructure and facilities, as well as an increase in medical tourism; availability and accessibility of quality healthcare services; rise in ophthalmic care expenditure by governments; and demand for minimally invasive surgeries due to increasing population, particularly from China and India, are some of the drivers expected to fuel regional growth during the forecast period.
 
LIST OF KEY COMPANIES PROFILED:
  • ABBVIE INC. (ALLERGAN)
  • ASICO LLC
  • GLAUKOS CORPORATION
  • ISTAR MEDICAL SA
  • IVANTIS INC.
  • LUMENIS LTD.
  • ZIEMER OPHTHALMIC SYSTEMS AG
  • NOVARTIS INTERNATIONAL AG (ALCON INC.)
  • SANTEN PHARMACEUTICAL CO. LTD.
  • CARL ZEISS MEDITEC AG
Recent Development:
  • In June 2022, a micro invasive glaucoma implanted surgery device is being developed by iSTAR Medical, a Belgian startup, and AbbVie recently announced it would pay USD 60 million for the rights to purchase iSTAR Medical. iSTAR is now registering for a premarket approval study in order to market the device in the US. Until this trial is finished, AbbVie is helping to create and market the MINIject device.
REPORT SCOPE AND SEGMENTATION
 
Attributes Details
Market Size in 2022 USD 315.2 Million
Market Forecast in 2030 USD 2458.03 Million
Compound Annual Growth Rate 34.10 %
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Surgery, By Target, By Product, By End User and By Geography
By Surgery
  • Glaucoma in Conjunction with Cataract
  • Stand Alone Glaucoma
By Target
  • Trabecular Meshwork
  • Suprachoroidal Space
  • Others
By Product
  • MIGS Stents
  • MIGS Shunts
  • Others (Trabectome/micro-impants/micro-catheters)
By End User
  • Eye Hospitals
  • Ophthalmology Clinics
  • Outpatient Surgical Centers
By Region
  • North America: U.S and Canada
  • Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
  • APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Chile
  • The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2022
Historical Year 2016-2021
Forecast Year 2023-2030
Chapter 1    Preface

    1.1    Report Scope and Description
        1.1.1    Study Purpose
        1.1.2    Target Audience
        1.1.3    USP and Key Offerings
    1.2    Key Benefits for Stakeholders
    1.3    Report Scope

Chapter 2    Report Summary

    2.1    Key Findings
        2.1.1    Top Investment Pockets
    2.2    Market Snapshot: Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market
    2.3    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, 2018 – 2028 (US$ Mn)

Chapter 3    COVID 19 Impact Analysis

    3.1    Impact Assessment of COVID-19 Pandemic, By Region
        3.1.1    North America: Impact of COVID-19 Pandemic
        3.1.2    Europe: Impact of COVID-19 Pandemic
        3.1.3    Asia pacific: Impact of COVID-19 Pandemic
        3.1.4    Latin America: Impact of COVID-19 Pandemic
        3.1.5    Middle-East and Africa: Impact of COVID-19 Pandemic
    3.2    Key Strategies Undertaken by Companies to Tackle COVID-19
    3.3    Quarterly Market Revenue by Region 2021 & 2022
    3.4    Pre COVID-19 Market Revenue, By Region, 2016-2019        (USD Million)
    3.5    Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    3.6    Short Term Dynamics
    3.7    Long Term Dynamics

Chapter 4    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Segment Analysis

    4.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Market Overview, By Surgery Segment
        4.1.1    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue Share, By Surgery, 2022 & 2028 (Value, %)
    4.2    Glaucoma in Conjunction with Cataract
        4.2.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        4.2.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        4.2.3    Key Market Trends, Growth Factors, & Opportunities
    4.3    Stand Alone Glaucoma
        4.3.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        4.3.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        4.3.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 5    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Target Segment Analysis

    5.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Market Overview, By Target Segment
        5.1.1    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue Share, By Target, 2022 & 2028 (Value, %)
    5.2    Trabecular Meshwork
        5.2.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        5.2.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.2.3    Key Market Trends, Growth Factors, & Opportunities
    5.3    Suprachoroidal Space
        5.3.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        5.3.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.3.3    Key Market Trends, Growth Factors, & Opportunities
    5.4    Others
        5.4.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        5.4.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.4.3    Key Market Trends, Growth Factors, & Opportunities
        
Chapter 6    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product Segment Analysis

    6.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Market Overview, By Product Segment
        6.1.1    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Value Share, By Product, 2021 & 2028 (Value, %)
    6.2    MIGS Stents
        6.2.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        6.2.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.2.3    Key Market Trends, Growth Factors, & Opportunities
    6.3    MIGS Shunts
        6.3.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        6.3.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.3.3    Key Market Trends, Growth Factors, & Opportunities
    6.4    Others (Trabectome/micro-impants/micro-catheters)
        6.4.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        6.4.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.4.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 7    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By End User Segment Analysis

    7.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Market Overview, By End User Segment
        7.1.1    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue Share, By End User, 2022 & 2028 (Value, %)
    7.2    Eye Hospitals
        7.2.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        7.2.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        7.2.3    Key Market Trends, Growth Factors, & Opportunities
    7.3    Ophthalmology Clinics
        7.3.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        7.3.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        7.3.3    Key Market Trends, Growth Factors, & Opportunities
    7.4    Outpatient Surgical Centers
        7.4.1    Micro Invasive Glaucoma Surgery (MIGS) Devices Share Forecast, By Region (USD Million)
        7.4.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        7.4.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 8    Micro Invasive Glaucoma Surgery (MIGS) Devices Market – Regional Analysis, 2022 – 2028

    8.1    Micro Invasive Glaucoma Surgery (MIGS) Devices market Overview, by Region Segment
        8.1.1    Global Micro Invasive Glaucoma Surgery (MIGS) Devices market Revenue Share, By Region, 2022 & 2028
        8.1.2    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Region, 2017 – 2028 (US$ Mn)
        8.1.3    Global Micro Invasive Glaucoma Surgery (MIGS) Devices market Revenue, By Surgery, 2017 – 2028 (US$ Mn)
        8.1.4    Global Micro Invasive Glaucoma Surgery (MIGS) Devices market Revenue, By Target, 2017 – 2028 (US$ Mn)
        8.1.5    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Product, 2017 – 2028 (US$ Mn)
        8.1.6    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By End User, 2017 – 2028 (US$ Mn)
    8.2    North America
        8.2.1    North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        8.2.2    North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Surgery, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.2.3    North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Target, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.2.4    North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Product, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.2.5    North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.2.6    U.S. Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.2.7    Canada Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.2.8    Mexico Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    8.3    Europe
        8.3.1    Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        8.3.2    Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Surgery, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.3.3    Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Target, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.3.4    Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Product, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.3.5    Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.3.6    Germany Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.3.7    France Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.3.8    U.K. Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.3.9    Italy Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.3.10    Spain Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.3.11    Rest of Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    8.4    Asia Pacific
        8.4.1    Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        8.4.2    Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Surgery, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.4.3    Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Target, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.4.4    Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Product, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.4.5    Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.4.6    China Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.4.7    Japan Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.4.8    India Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.4.9    South Korea Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.4.10    South-East Asia Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.4.11    Rest of Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    8.5    Latin America
        8.5.1    Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        8.5.2    Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Surgery, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.5.3    Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Target, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.5.4    Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Product, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.5.5    Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.5.6    Brazil Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.5.7    Argentina Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.5.8    Rest of Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    8.6    The Middle-East and Africa
        8.6.1    The Middle-East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        8.6.2    The Middle-East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Surgery, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.6.3    The Middle-East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Target, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.6.4    The Middle-East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By Product, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.6.5    The Middle-East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        8.6.6    GCC Countries Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.6.7    South Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        8.6.8    Rest of Middle-East Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)

Chapter 9    Micro Invasive Glaucoma Surgery (MIGS) Devices Market – Industry Analysis

    9.1    Introduction
    9.2    Market Drivers
        9.2.1    Driving Factor 1 Analysis
        9.2.2    Driving Factor 2 Analysis
    9.3    Market Restraints
        9.3.1    Restraining Factor Analysis
    9.4    Market Opportunities
        9.4.1    Market Opportunity Analysis
    9.5    Porter’s Five Forces Analysis
    9.6    PEST Analysis
    9.7    Regulatory Landscape
    9.8    Technology Landscape
    9.9      Value Chain Analysis

Chapter 10    Competitive Landscape

    10.1    Company Market Share Analysis – 2022
        10.1.1    Global Micro Invasive Glaucoma Surgery (MIGS) Devices market: Company Market Share, 2022
        10.1.2    Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market: Company Market Share, 2022
    10.2    Strategic Developments
        10.2.1    Acquisitions & Mergers
        10.2.2    New Product Launch
        10.2.3    Regional Expansion
    10.3    Company Strategic Developments – Heat Map Analysis

Chapter 11    Company Profiles

    11.1    ABBVIE INC. (ALLERGAN)
        11.1.1    Company Overview
        11.1.2    Key Executives
        11.1.3    Product Portfolio
        11.1.4    Financial Overview
        11.1.5    Operating Business Segments
        11.1.6    Business Segment Performance
        11.1.7    Recent Developments
    11.2    ASICO LLC
    11.3    GLAUKOS CORPORATION
    11.4    ISTAR MEDICAL SA
    11.5    IVANTIS INC.
    11.6    LUMENIS LTD.
    11.7    ZIEMER OPHTHALMIC SYSTEMS AG
    11.8    NOVARTIS INTERNATIONAL AG (ALCON INC.)
    11.9    SANTEN PHARMACEUTICAL CO. LTD.
    11.10    CARL ZEISS MEDITEC AG

Chapter 12    Research Methodology

    12.1    Research Methodology
    12.2    Phase I – Secondary Research
    12.3    Phase II - Data Modeling
        12.3.1    Company Share Analysis Model
        12.3.2    Revenue Based Modelling
    12.4    Phase III – Primary Research
    12.5    Research Limitations
        12.5.1    Assumptions
No Methodology
No Available